Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model

Prostate Cancer and Prostatic Diseases volume 3, pages 280–282 (2000)Cite this article

Abstract

In most clinical trials of intermittent androgen deprivation (IAD), the decision to stop androgen withdrawal is based on monitoring PSA levels, waiting for its drop to nadir. Based on in vitro pre-clinical studies, a modified ‘on–off’ schedule of short intervals of androgen deprivation, designated pulsed androgen deprivation (PAD), is proposed to destroy androgen dependent (AD) cells more gradually and to conserve their androgen-independent (AI) inhibitory potential for longer periods, resulting in an overall prolongation of time to hormone resistant progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, CA, USA

    AJ Pantuck, A Zismon, C-L Tso & AS Belldegrun

Authors
  1. AJ Pantuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Zismon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C-L Tso
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. AS Belldegrun
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pantuck, A., Zismon, A., Tso, CL. et al. Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model. Prostate Cancer Prostatic Dis 3, 280–282 (2000). https://doi.org/10.1038/sj.pcan.4500473

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500473

Keywords

Search

Advanced search

Quick links